11 – 20 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
(
- Contribution to journal › Article
-
Mark
Limbic encephalitis in a neuroscientist : CASPR 2 antibody-associated disease after antigen exposure
(
- Contribution to journal › Article
-
Mark
Infection Risks among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
(
- Contribution to journal › Article
- 2019
-
Mark
Functional connectivity changes in core resting state networks are associated with cognitive performance in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
White matter lesions and brain atrophy in systemic lupus erythematosus patients : correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Functional Connectivity Changes in Systemic Lupus Erythematosus : A Resting-State Study
(
- Contribution to journal › Article
-
Mark
Altered white matter microstructure in lupus patients : A diffusion tensor imaging study
(
- Contribution to journal › Article
- 2017
-
Mark
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis : Recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
(
- Contribution to journal › Article
- 2014
-
Mark
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
(
- Contribution to journal › Article
-
Mark
Costs and quality of life in multiple sclerosis patients with spasticity.
(
- Contribution to journal › Article